Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
SYNBIOTIC SE logo — Integrated Investment Platform for the Cannabis and Hemp Mar...

SYNBIOTIC SE

Integrated Investment Platform for the Cannabis and Hemp Market. Your Gateway to Germany and Europe.

Founded 1982 Germany Dusseldorf, Germany 5 employees Post-IPO Equity Total: $5.49M Biotechnology, Health and Wellness

General Information

Company Name SYNBIOTIC SE
Founded Year 1982
Location Germany Dusseldorf, Germany
Employees 5
Industries Biotechnology, Health and Wellness
Funding Stage Post-IPO Equity
Business Model Platform, B2B, B2B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with SYNBIOTIC SE. To contact SYNBIOTIC SE, visit synbiotic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SYNBIOTIC SE compare?

A PDF of SYNBIOTIC SE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SYNBIOTIC SE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SYNBIOTIC SE

SYNBIOTIC SE, founded in 1982, is an integrated investment platform with a focus on the cannabis and hemp markets in Germany and across Europe. Positioned as a publicly traded holding company, the firm strategically invests in ventures that span the entire value chain, from seed to shelf, encompassing both horizontal and vertical integration.

The company emphasizes its strength in Medizinalcannabis and industrial hemp, leveraging cannabinoid-based innovations to advance its mission. The Buy and Build Strategy employed by SYNBIOTIC SE fosters synergies across cultivation, import, R&D, production, and distribution, underpinned by stringent quality and compliance standards.

For investors, SYNBIOTIC presents a robust and diverse platform offering stability and growth potential. The latest investment was a €3.00 million Post-IPO Equity, involving notable investor Frank Otto on 22 August 2023. This recent capital injection reinforces the company’s strategic positioning in the Biotechnology and Health and Wellness sectors.

Business keywords: Integrated Investment Platform, Cannabis Market, Hemp Market, Medizinalcannabis, Industriehanf, Cannabinoid-Based Innovations, Seed to Shelf, Buy and Build Strategy, Research and Development, Production, Distribution, Quality and Compliance Standards, Chronic Pain Treatment, Stress Management, Sleep Disorder Solutions

Services & Products

Cultivation and production of cannabis and hemp
Development and distribution of cannabinoid-based products
Strategic investments in cannabis and hemp sectors
Research and development in hemp and cannabis products

Target Customers

Investors in the cannabis and hemp industry Patients using medicinal cannabis Retailers of hemp and cannabis products Businesses seeking sustainable hemp solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity €3.00M 1
Frank Otto
22 Aug 2023
Post IPO Equity €2.49M 1
Bruce Linton
31 Oct 2022

SYNBIOTIC SE Alternatives & Competitors

View All Alternatives
SYNBIOTIC SE vs
Ascendant Biotech Corporation
Ascendant Biotech Corporation Thailand

Bringing Groundbreaking Technologies to the World

4 employees
Biotechnology, Health Care
SYNBIOTIC SE vs
iVascular
iVascular Germany

From the heart

307 employees
Biotechnology, Health Care
SYNBIOTIC SE vs
Biogen
Biogen United States

Innovative therapies worldwide for people living with serious neurological and neurodegenerative dis...

IPO
7823 employees
Biotechnology, Health Care
View all alternatives

FAQ About SYNBIOTIC SE

Integrated Investment Platform for the Cannabis and Hemp Market. Your Gateway to Germany and Europe.
SYNBIOTIC SE was founded in 1982.
SYNBIOTIC SE is headquartered in Dusseldorf, Germany.
SYNBIOTIC SE operates in Biotechnology and Health and Wellness. Its work centres on Integrated Investment Platform, Cannabis Market, Hemp Market and Medizinalcannabis. Its customers include Investors in the cannabis and hemp industry, Patients using medicinal cannabis and Retailers of hemp and cannabis products.
SYNBIOTIC SE has a Platform, B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
SYNBIOTIC SE has approximately 5 employees.
SYNBIOTIC SE has completed 2 funding rounds, raising a total of $5.49M. The latest funding stage is Post-IPO Equity.
SYNBIOTIC SE offers: Cultivation and production of cannabis and hemp, Development and distribution of cannabinoid-based products, Strategic investments in cannabis and hemp sectors, Research and development in hemp and cannabis products.
Top alternatives and competitors to SYNBIOTIC SE include Ascendant Biotech Corporation, iVascular, Biogen, BIORCHESTRA Co., Ltd., Neurohacker Collective. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SYNBIOTIC SE and Ascendant Biotech Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SYNBIOTIC SE, https://bouncewatch.com/company/synbiotic, updated 14 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout